Someone else's clock has started running against them: the company is being paid to solve a problem that is already cost
The model's full reasoning — Q3 2022 call → NOWe need to answer YES/NO based on transcript. The question asks: does management describe that counterparties (customers/patients/surgeons/hospitals) are already losing something real and ongoing for as long as they do not have what the company provides, and that this accumulating loss is visible in their behavior? Need to identify if there is a "running meter" on the other side and the other side is acting like it. The transcript discusses SI-BONE, products for SI joint fusion, trauma, deformity. There is talk about reimbursement increases, surgeon adoption, active surgeon growth, product demand, Granite supply constraints. But does management describe customers losing something real and ongoing while they wait? For patients with SI joint pain, there is chronic pain, but is that described as a running meter? Management talks about "deblitating sacral fragility fractures" with high one-year mortality, but that is about condition. The question is about counterparties (patients, surgeons, hospitals) losing due to not having the company's product. The transcript is mostly about company growth, surgeon adoption, product launches. There is mention of "strong demand" and "surgeon interest" but not specifically that counterparties are incurring costs or losing opportunity as time passes. There is mention of "fragility fractures" with mortality, but that is a patient condition, not directly a running meter in the business transaction sense. Also "75% of patients with fragility fractures are currently treated with Bedrock" - but that's not about the company's counterparties losing something due to delay. The reimbursement increase is a tailwind, not a customer loss. The company is seeing "strong demand" and "surgeon engagement" but that could be due to product benefits. There is no explicit description that, for example, hospitals or surgeons are losing money or facing penalties because they don't have the product. They are adopting because it's beneficial. The constraint is supply chain for Granite, but that is company-side, not customer-side. Thus, the answer is NO. Need to ensure no hidden mention. The transcript mentions "we are being chased" but not in those words. There is no running meter on counterparty side. The question is specific. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
SYM · Q3 2022 → YESThe question is: Does management describe that ITS COUNTERPARTIES ARE ALREADY LOSING SOMETHING REAL AND ONGOING — money, output, access, standing, time, or an opportunity of their own — FOR AS LONG AS...YES The transcript shows management describing customers' ongoing pain from labor shortages and broken supply chains that prevent them from handling demand, with customers actively clamoring for faster deployments and wanting the system as quickly as possible.
CRL · Q2 2022 → YESThe question is whether management describes that their counterparties are already losing something real and ongoing — money, output, access, standing, time, or an opportunity — for as long as they do...
GTES · Q4 2021 → YESThe question is: Does management describe that ITS COUNTERPARTIES ARE ALREADY LOSING SOMETHING REAL AND ONGOING — money, output, access, standing, time, or an opportunity of their own — FOR AS LONG AS...